Theratechnologies Доход Y / Y

Что обозначает Доход Y / Y в Theratechnologies?

Доход Y / Y Theratechnologies Inc. является 10.25%

Какое определение для Доход Y / Y?

Ежегодный рост выручки за последние 3 года является ростом выручки одного года к следующему, усреднённый за последние 3 года.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Доход Y / Y компаний в Health Care сектор на NASDAQ по сравнению с Theratechnologies

Что делает Theratechnologies?

theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.

Компании с доход y / y похож на Theratechnologies